144 related articles for article (PubMed ID: 4474966)
1. The clinical significance of highly purified pig-insulin preparations.
Deckert T; Andersen OO; Poulsen JE
Diabetologia; 1974 Dec; 10(6):703-8. PubMed ID: 4474966
[No Abstract] [Full Text] [Related]
2. Treatment of insulin lipoatrophy with monocomponent insulin.
Teuscher A
Diabetologia; 1974 Jun; 10(3):211-4. PubMed ID: 4845721
[No Abstract] [Full Text] [Related]
3. Intermediate-acting insulin preparations: NPH and lente.
Deckert T
Diabetes Care; 1980; 3(5):623-6. PubMed ID: 7192205
[TBL] [Abstract][Full Text] [Related]
4. Serum levels of insulin-binding antibodies in diabetic patients treated with monocomponent insulin.
Czyzyk A; Lawecki J; Rogala H; Miedzińska E; Popik-Hankiewicz A
Diabetologia; 1974 Jun; 10(3):233-6. PubMed ID: 4845724
[No Abstract] [Full Text] [Related]
5. [Proinsulin and a-component antibodies in diabetics treated with monocomponent and conventional insulin].
Gamba S; Barbero PL; Bollati C; Castellazzi R; D'Adda A; Bruni B
Minerva Dietol Gastroenterol; 1979; 25(3):309-14. PubMed ID: 400003
[No Abstract] [Full Text] [Related]
6. Proinsulin and A-component antibodies in diabetics after long-term monocomponent insulin treatment.
Bruni B; Gamba S; Regis G; Turco GL
Diabetologia; 1978 Mar; 14(3):165-9. PubMed ID: 566232
[TBL] [Abstract][Full Text] [Related]
7. Circulating IgG antibody to protamine in patients treated with protamine-insulins.
Kurtz AB; Gray RS; Markanday S; Nabarro JD
Diabetologia; 1983 Oct; 25(4):322-4. PubMed ID: 6196244
[TBL] [Abstract][Full Text] [Related]
8. The future of basal insulin.
Shah VN; Moser EG; Blau A; Dhingra M; Garg SK
Diabetes Technol Ther; 2013 Sep; 15(9):727-32. PubMed ID: 23965036
[No Abstract] [Full Text] [Related]
9. [Experience of using biosulin P and biosulin H for the treatment of diabetes mellitus].
Dedov II; Balabolkin MI
Ter Arkh; 2004; 76(1):65-8. PubMed ID: 15108443
[No Abstract] [Full Text] [Related]
10. [Is proinsulin contamination of commercial insulin preparations responsible for the stimulation of insulin antibodies?].
Kerp L; Steinhilber S; Kasemir H
Klin Wochenschr; 1970 Jul; 48(14):884-5. PubMed ID: 5535446
[No Abstract] [Full Text] [Related]
11. Newer basal insulin analogues: degludec, detemir, glargine.
Kalra S
J Pak Med Assoc; 2013 Nov; 63(11):1442-4. PubMed ID: 24392539
[No Abstract] [Full Text] [Related]
12. U-500 insulin in the treatment of antibody-mediated insulin resistance.
Nathan DM; Axelrod L; Flier JS; Carr DB
Ann Intern Med; 1981 May; 94(5):653-6. PubMed ID: 7015948
[TBL] [Abstract][Full Text] [Related]
13. The immunogenic properties of highly purified insulin preparations: The clinical importance of insulin-binding antibodies.
Anderson OO
Acta Endocrinol (Copenh); 1975 Apr; 78(4):723-35. PubMed ID: 1173962
[TBL] [Abstract][Full Text] [Related]
14. [Immunogenicity of MC Lente Novo insulin].
Rogala H; Lawecki J; Czyzyk A
Pol Arch Med Wewn; 1986 Sep; 76(3):172-6. PubMed ID: 3554163
[No Abstract] [Full Text] [Related]
15. [The place of "monocomponent" insulins in diabetes mellitus therapy].
Teuscher A
Schweiz Med Wochenschr; 1975 Apr; 105(16):485-94. PubMed ID: 1215860
[TBL] [Abstract][Full Text] [Related]
16. Human insulin.
Roberts RJ
Iowa Med; 1984 Mar; 74(3):116-8. PubMed ID: 6373658
[No Abstract] [Full Text] [Related]
17. Clinical trial with monocomponent lente insulins. Preliminary report.
Bruni B; D'Alberto M; Osenda M; Ricci C; Turco GL
Diabetologia; 1973 Dec; 9(6):492-8. PubMed ID: 4589824
[No Abstract] [Full Text] [Related]
18. A method for the determination of plasma insulin antibodies and its application in normal and diabetic subjects.
Sebriakova M; Little JA
Diabetes; 1973 Jan; 22(1):30-40. PubMed ID: 4734254
[No Abstract] [Full Text] [Related]
19. [KH metabolic pattern and insulin antibody level during treatment of diabetes mellitus with conventional and/or prepurified insulin preparations].
Göbel P; Kramer W; Heni F
Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1426-9. PubMed ID: 611859
[No Abstract] [Full Text] [Related]
20. Highly purified insulin.
Ginsberg BH
J Iowa Med Soc; 1981 May; 71(5):214-5. PubMed ID: 7017024
[No Abstract] [Full Text] [Related]
[Next] [New Search]
